Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuetong Wang

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Scientific Reports|September 6, 2017
Cell Division Cycle 42 plays a Cell type-Specific role in Lung TumorigenesisChao Zheng, Yuetong Wang, Liu Yang, et al.
Cell Chemical Biology|June 21, 2024
NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancersXiaotong Zhu, Ye Li, Haixia Liu, et al.
Elife|May 13, 2022
FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cellsYanchun Zhang, Xuexue Xiong, Qi Zhu, et al.
European Journal of Medicinal Chemistry|May 17, 2024
Design, synthesis and biological evaluation of 4-(indolin-1-yl)-6-substituted-pyrido[3,2-d]pyrimidine derivatives as Mnk1/2 inhibitorsKun Xing, Huimin Zhang, Shuxiang Wang, et al.
Journal of Medicinal Chemistry|September 13, 2021
Optimization of 4,6-Disubstituted Pyrido[3,2-<i>d</i>]pyrimidines as Dual MNK/PIM Inhibitors to Inhibit Leukemia Cell GrowthYu Han, Huimin Zhang, Shuxiang Wang, et al.
Cell Reports|August 11, 2021
NAD<sup>+</sup> supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cellsYuetong Wang, Fei Wang, Lihua Wang, et al.
Cancer Cell|May 5, 2015
LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic ResponseFuming Li, Xiangkun Han, Fei Li, et al.
Cell Reports|October 13, 2023
Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasivenessShengmiao Chen, Yiran Wu, Yang Gao, et al.
National Science Review|December 3, 2021
Targeting HSPA1A in ARID2-deficient lung adenocarcinomaXue Wang, Yuetong Wang, Zhaoyuan Fang, et al.
Nature Structural & Molecular Biology|January 4, 2024
THEMIS is a substrate and allosteric activator of SHP1, playing dual roles during T cell developmentJiali Zhang, Zhenzhou Jiang, Xueyuan Zhang, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Scientific Reports|September 6, 2017
Cell Division Cycle 42 plays a Cell type-Specific role in Lung TumorigenesisChao Zheng, Yuetong Wang, Liu Yang, et al.
Cell Chemical Biology|June 21, 2024
NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancersXiaotong Zhu, Ye Li, Haixia Liu, et al.
Elife|May 13, 2022
FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cellsYanchun Zhang, Xuexue Xiong, Qi Zhu, et al.
European Journal of Medicinal Chemistry|May 17, 2024
Design, synthesis and biological evaluation of 4-(indolin-1-yl)-6-substituted-pyrido[3,2-d]pyrimidine derivatives as Mnk1/2 inhibitorsKun Xing, Huimin Zhang, Shuxiang Wang, et al.
Journal of Medicinal Chemistry|September 13, 2021
Optimization of 4,6-Disubstituted Pyrido[3,2-<i>d</i>]pyrimidines as Dual MNK/PIM Inhibitors to Inhibit Leukemia Cell GrowthYu Han, Huimin Zhang, Shuxiang Wang, et al.
Cell Reports|August 11, 2021
NAD<sup>+</sup> supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cellsYuetong Wang, Fei Wang, Lihua Wang, et al.
Cancer Cell|May 5, 2015
LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic ResponseFuming Li, Xiangkun Han, Fei Li, et al.
Cell Reports|October 13, 2023
Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasivenessShengmiao Chen, Yiran Wu, Yang Gao, et al.
National Science Review|December 3, 2021
Targeting HSPA1A in ARID2-deficient lung adenocarcinomaXue Wang, Yuetong Wang, Zhaoyuan Fang, et al.
Nature Structural & Molecular Biology|January 4, 2024
THEMIS is a substrate and allosteric activator of SHP1, playing dual roles during T cell developmentJiali Zhang, Zhenzhou Jiang, Xueyuan Zhang, et al.
Pageof 10